These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30143816)

  • 1. Relationship between KRAS mutations and dual time point
    Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H
    Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
    Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H
    Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
    Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
    J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of
    Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
    Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.
    Krikelis D; Skoura E; Kotoula V; Rondogianni P; Pianou N; Samartzis A; Xanthakis I; Fountzilas G; Datseris IE
    Anticancer Res; 2014 May; 34(5):2571-9. PubMed ID: 24778079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between KRAS mutation and
    Cho A; Jo K; Hwang SH; Lee N; Jung M; Yun M; Hwang HS
    Abdom Radiol (NY); 2017 Jun; 42(6):1621-1626. PubMed ID: 28161825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between
    Liu X; Wang SC; Ni M; Xie Q; Zhang YF; Lv WF; Geng GY
    Abdom Radiol (NY); 2022 Apr; 47(4):1255-1264. PubMed ID: 35138462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the value of delayed 18 F-FDG PET/CT images in diagnosing small colorectal cancer liver metastases in patients with hypothyroidism based on diagnostic accuracy and image standardized uptake value.
    Pei Y; Wang Z; Hao S; Tong Y; Wu R; Qiao X; Liu Y; Zhang G
    Nucl Med Commun; 2024 May; 45(5):396-405. PubMed ID: 38372033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.
    Lee JH; Kang J; Baik SH; Lee KY; Lim BJ; Jeon TJ; Ryu YH; Sohn SK
    Medicine (Baltimore); 2016 Jan; 95(1):e2236. PubMed ID: 26735530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
    Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
    Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does dual-time-point
    Wu B; Zhao Y; Zhang Y; Tan H; Shi H
    Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations among KRAS Mutation, Microsatellite Instability, and 18F-FDG Uptake in Colon Cancer.
    Lee SS; Choi SJ; Park JS
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3501-3506. PubMed ID: 36308376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between PET/CT parameters and KRAS expression in colorectal cancer.
    Chen SW; Chiang HC; Chen WT; Hsieh TC; Yen KY; Chiang SF; Kao CH
    Clin Nucl Med; 2014 Aug; 39(8):685-9. PubMed ID: 24978328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.
    Gültekin MA; Türk HM; Beşiroğlu M; Toprak H; Yurtsever I; Yilmaz TF; Sharifov R; Uysal Ö
    Eur J Radiol; 2020 Apr; 125():108895. PubMed ID: 32109834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer.
    Kawada K; Nakamoto Y; Kawada M; Hida K; Matsumoto T; Murakami T; Hasegawa S; Togashi K; Sakai Y
    Clin Cancer Res; 2012 Mar; 18(6):1696-703. PubMed ID: 22282467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
    Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of
    Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
    Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.